PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predat... حسب Alexandra M. Campbell (3284094)

الموضوعات:

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). حسب Juan-Juan Xu (18590868)

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Contemporary mean inundation fraction in the Amazon basin. حسب Nic Gedney (19762301)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. حسب Justine Guguin (9088672)

Exposure to high temperatures decreases the lifespan of <i>Strongyloides</i> spp. FLFs. حسب Ben T. Gregory (20442502)

Comparison of WEI values for two scenarios. حسب Danuta Roman-Liu (8532645)

الموضوعات:

Average stability values (mean ± standard deviation) and statistical results. حسب Hyung Suk Yang (20442438)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. حسب Peiqi Yin (6533747)

Relationship between monthly NDVI and climatic variables values (Tmax, maximum air temperature; P, precipitation; VPD, vapor pressure deficit), in areas with decreasing trends (<i>p</i> < 0.05). حسب Oswaldo Maillard (20660661)

Changes in work exposure as a function of relative time for seven fixed values of mean exposure. حسب Danuta Roman-Liu (8532645)

الموضوعات:

Depletion of most candidate CIA pathway proteins leads to a decrease in protein translation in <i>Toxoplasma gondii</i> parasites. حسب Evie R. Hodgson (21866946)

Proportion of the increase (green) or decrease (red) in forest cover in areas with different fire recurrences in Africa, according to the Mann-Kendall test and statistically signif... حسب Oswaldo Maillard (20660661)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات: